Table 1. Patient characteristics.
| Variables | IPHC group (N=23) | Surgery group (N=10) | Total (N=33) | P value |
|---|---|---|---|---|
| Mean age (± SD) | 60.8 (±7.68) | 65.0 (±5.21) | 62.1 (±7.21) | 0.124 |
| Gender | 0.259 | |||
| M | 10 (43.5%) | 7 (70.0%) | 17 (51.5%) | |
| F | 13 (56.5%) | 3 (30.0%) | 16 (48.5%) | |
| Smoking history | 0.136 | |||
| Never smoker | 17 (73.9%) | 4 (40.0%) | 21 (63.6%) | |
| Ex-smoker | 4 (17.4%) | 5 (50.0%) | 9 (27.3%) | |
| Current smoker | 2 (8.7%) | 1 (1.0%) | 3 (9.1%) | |
| T stage | 0.035 | |||
| 2a | 13 (56.5%) | 1 (1.0%) | 14 (42.4%) | |
| 3 | 6 (26.1%) | 4 (40.0%) | 10 (30.3%) | |
| 4 | 4 (17.4%) | 5 (50.0%) | 9 (27.3%) | |
| N stage | 0.080 | |||
| 0 | 10 (43.5%) | 2 (20.0%) | 12 (36.4%) | |
| 1 | 4 (17.4%) | 0 (0.0%) | 4 (12.1%) | |
| 2 | 9 (39.1%) | 8 (80.0%) | 17 (51.5%) | |
| SUVmax (± SD) | 5.4 (±2.62) | 6.1 (±1.67) | 5.7 (±2.27) | 0.517 |
| Operation | 0.100 | |||
| Wedge | 8 (34.8%) | 2 (20.0%) | 10 (30.3%) | |
| Segmentectomy | 1 (4.3%) | 0 (0.0%) | 1 (3.0%) | |
| Lobectomy | 13 (56.5%) | 4 (40.0%) | 17 (51.5%) | |
| Bilobectomy | 1 (4.3%) | 2 (20.0%) | 3 (9.1%) | |
| Pneumonectomy | 0 (0.0%) | 2 (20.0%) | 2 (6.1%) | |
| Neoadjuvant therapy | 0.485 | |||
| Negative | 20 (87.0%) | 8 (80.0%) | 28 (84.8%) | |
| Positive | 3 (13.0%) | 2 (20.0%) | 5 (15.2%) |
IPHC, intrapleural perfusion hyperthermic chemotherapy; SD, standard deviation.